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A Dominican eonate carrying anew abnormal hemoglobin, hemoglobin Roseau Pointe-&Pitre crJ?,90 (F6) 
Glu + Gly, was detected inGuadeloupe during application of a cord blood screening program. This variant 
behaved in isoelectrofocusing as an Hb D, and displayed instability and low whole blood oxygen affinity. 
In the affected family it was present, either isolated, or in association with a fi+ thalassemia tr it. 
Hemoglobinopathy J variant-Guadeloupe B variant-Dominica Hb Roseau-Pointe a Pitre 
Molecular instability Low oxygen affinity Structural analysis 
1. INTRODUCTION 2. MATERIALS AND METHODS 
A critical point in the field of human 
hemoglobin variants is to be able to establish 
rapidly whether a newly detected rare variant is 
undescribed, and if it induces a molecular dysfunc- 
tion. During the course of a systematic ord blood 
screening program developed in Guadeloupe in the 
last 2 years, approx. 1 neonate in 1000 was found 
to be a carrier of a rare variant of a hemoglobin p 
gene. Most of these cases are Hb D Korle-Bu or Hb 
D Punjab traits. Electrophoretical data, stability 
studies and oxygen affinity determinations permit- 
ted us to postulate that one of these Hb D variants 
observed during this cord blood screening program 
was not previously described, at least not in 
Guadeloupe. Therefore, we performed a structural 
study which demonstrated a Glu to Gly substitu- 
tion at the p90 (F6) residue. This variant, 
homologous to Hb Agenogi Glu-+Lys p90 (F6), 
a low oxygen affinity abnormal Hb [ 11, was named 
Hb Roseau-Pointe a Pitre. 
+ To whom correspondence should be addressed 
Hematological data were obtained by standard 
procedures. Isoelectrofocusing (IEF) was carried 
out on thin-layer polyacrylamide gels in a pH 6-9 
gradient [2]. The electrophoretic protocol of 
Schneider [3] was followed. Electrophoresis on 
acetate cellulose strips (Sebia, France) was per- 
formed with Tris-EDTA-borate buffer, pH 8.6. 
Citrate agar electrophoresis (pH 6.2) was per- 
formed with a commercial kit (Titan IV-Helena) 
and globin chain electrophoresis was carried out in 
6 M urea, 1% ,&mercaptoethanol (pH 6 and 9) on 
cellulose acetate strips (Sebia). Acid urea Triton 
polyacrylamide gel (PAGE) electrophoresis was 
performed as in [4]. Densitometry of IEF slabs and 
other electrophoretic profiles were obtained with a 
Cellosystem Sebia (France) instrument. Quan- 
tification of HbF was achieved as in [5] (normal 
range: O-l 070) and the HbAz level was measured 
with the microchromatographic procedure [6] 
(normal range 2.1-3.1 Ore). Stability was checked 
by the isopropanol test [7]. The oxygen affinity of 
the whole blood was determined with an Aminco 
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Hemoscan (Silver Springs, USA) and the 2,3-DPG 
assay was performed as in [8]. 
Structural analysis was conducted on the 
aminoethylated abnormal B chain prepared by 
CM-cellulose (CM52, Whatman) chromatography 
[9] and desalted through a Biogel PZ column 
(BioRad). Tryptic peptide separation of the Hb 
Roseau-Pointe a Pitre ,f3 chain was achieved by 
reverse phase HPLC using a microbondapak Cl8 
column (Waters Assoc.) [lo] with a precolumn and 
a guard column of the same phase, on a Beckman 
332 apparatus equipped with a computing 
integrator. 
3. RESULTS 
3.1. Case report 
The trait was first discovered by IEF of the cord 
blood hemolysate of a black newborn, whose 
parents were of Dominican origin. A very low pro- 
portion of Hb AO was measured (-lo/o) compared 
to -10% for the Hb D variant. The isoelec- 
trofocusing point of this Hb D was similar to that 
of Hb D Korle-Bu, and thus distinctly more anodal 
than that of Hb S [2] as shown in fig.la; lane 2 
represents the propositus’ hemolysate at 2 months 
of age. Six months later, the proportions of the 
different Hbs in the hemolysate were: Hb D, 
62.5%; Hb A,,, 15.1%; Hb F, 17.3%; Hb AZ, 
5.3%. The mother carried the trait (fig.la) (Hb D, 
36%; Hb AZ, 2.2%) and the father had the typical 
biological features of afl thalassemia trait (Hb A2, 
a b 
Hb I- 
Hb Jc 
Hb A- - Hb A 
Hb F* - Hb S 
HbSC 
. 
Hb AzC - - 
12345 123 
Fig.1. (a) IEF of the propositus and the mother’s 
hemolysates. Lane 2, propositus, Hb D Roseau-Pointe a 
Pitre/fl+ thalassemia (age 2 months). Lane 4, mother, 
Hb A/Hb D Roseau-Pointe a Pitre. Lanes 1, 3, 5, 
controls. (b) Cellulose acetate strip electrophoresis. Lane 
1, Hb A/Hb D Korle-Bu; lane 2, Hb A/Hb D Roseau- 
Pointe a Pitre; lane 3, Hb A/Hb S. 
Y 
Fig.2. Elution profile of the tryptic digest of the 
aminoethylated p chain of hemoglobin Roseau-Pointe a 
Pitre by reverse phase HPLC. The amino acid 
composition of peptide T, is given in table 1. 
5.6%; MCV, 78 Fl). It was concluded that the pro- 
positus carried an association of Hb D and ,f3’ 
thalassemia traits. Hematological data for the pro- 
positus were at the same period: RBC, 4.54 x 
1012/1; Hb, 10.8 g/dl; PCV, 31.6%; MCV, 69.6 fl; 
MCH, 23.2 pg; reticulocytes, 33 x 109/1. The 
mother had a moderate microcytic anemia (RBC, 
4.77 x 1012/1; Hb, 11.9 g/dl; PCV, 36.7%; MCV, 
77 fl; MCH, 25 pg) explained by a post-partum 
iron deficiency. An cy thalassemia could not be ex- 
cluded but the family was not accessible for further 
studies. Despite the absence of overt hemolytic 
anemia, biological signs of an unstable 
hemoglobin were obvious. There were Heinz 
bodies in a large number of red cells after 3 h in- 
cubation with brilliant cresyl blue and the 
isopropanol test was positive after 10 min (control 
60 min), either with the propositus’ or the 
mother’s hemolysate. 
The electrophoretic mobilities, determined as 
proposed by Schneider and Barwick [I l] were: 
- 4.3 for cellulose acetate electrophoresis, pH 8.7; 
a value clearly different from that of Hb S and of 
Hb Korle Bu (fig.lb); 1.3 for citrate agar elec- 
trophoresis, pH 6.2; 17.4 and 18.2 for globin chain 
electrophoresis urea (6 M), pH 9.0 and 6.0, respec- 
tively; and 19.4 for acid urea Triton PAGE elec- 
trophoresis. These values did not correspond to 
any previously described variant [13]. The 
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Table 1 
Amino-acid composition of Hb Roseau-Pointe B Pitre 
/3TlO compared to that of normal /3TlO 
Residue 
GlY 
Thr 
Phe 
Ala 
Leu 
Ser 
Glu 
His 
CYs 
Asp 
LYS 
,&TlO Hb R.P?iP. @-II0 Hb A 
measured expected 
amino-acid amino-acid 
molar ratio molar ratio 
1.90 1 
1.90 2 
1.00 1 
1.20 1 
1.80 2 
1.10 1 
0.00 1 
0.90 1 
0.90 1 
1.20 1 
1.00 1 
mother’s whole blood AO was 38 mmHg (normal 
range, 27-29), with a 2,3-DPG level of 17.3 pM/g 
Hb (normal range, 13-17). The corresponding 
values were 35 mmHg and 17.7 GM/g Hb, respec- 
tively, in the propositus. 
trait: very low expression of the ,&* compared to 
the fl” gene at birth and slow disappearance of Hb 
F after birth. In this case, however, the instability 
of Hb Roseau-Pointe a Pitre probably also con- 
tributes to the relatively high Hb F level observed 
at 6 months. Hb Roseau-Pointe a Pitre is another 
illustration of the efficiency of both IEF and stan- 
dard electrophoretical mobilitites for the iden- 
tification of undescribed variants. IEF showed that 
the studied Hb D had a pZ very close to 3 rare Hbs 
D (2): Hb D Korle-Bu, Hb D Punjab, and Hb D 
Iran. Standard electrophoretic mobilities clearly 
indicted a distinct, and possibly new pattern ac- 
cording to published data [ 131. The most in- 
teresting feature was the slower mobility of Hb 
Roseau-Pointe a Pitre in citrate agar electro- 
phoresis which is the probable result of the disap- 
pearance of a negative charge in the vicinity of the 
central cavity [14]. Instability and low oxygen af- 
finity were further arguments for the identification 
of the abnormal hemoglobin as a new variant. 
3.2. Structural studies 
Separation of the TPCK-tryptic digest of the ab- 
normal aminoethylated fi chain by reverse phase 
HPLC demonstrated that the abnormality was 
located in peptide ,&TlO (fig.2). This peptide was 
not found at its normal position and appeared 
more hydrophobic, as it eluted before peptide 
@T12a. Amino-acid analysis (table 1) of this new 
peptide T, indicated an amino-acid composition 
corresponding to a peptide @IlO with the excep- 
tion that the single Glu residue F6 was missing, 
whereas one additional Gly was present. An iden- 
tical result was obtained upon amino-acid analysis 
of the abnormal peptide fllOa. From these data 
the structure of hemoglobin Roseau-Pointe P Pitre 
was assigned as ,&90 (F6) Glu-Gly. In the 
published sequence of /3 gene [12] the codon for 
Glu ,f390 is GAG; hence the probable genetic event 
is a substitution GAG-GGG (glycine). 
According to the three-dimensional hemoglobin 
model [15] position ,&90 (F6) occupies an external 
position on a helical segment close to the (Y& in- 
terface. As shown by Ackers and co-workers [la] 
and earlier investigators, most of the free energy 
difference between the T and R states is localised 
in this area, which has been one of the most con- 
served regions during evolutionary history. In 
mammals, p90 Glu is an invariant residue. 
Hemoglobin Roseau-Pointe a Pitre is the second 
variant with a substitution located at position 6 of 
the F helix, the other being Hb Agenogi @Xl 
Glu-Lys, a hemoglobin with decreased oxygen 
affinity [ 171. The interpretation of the low oxygen 
affinity in Hb Agenogi postulated a new intrachain 
salt bridge between the Lys (F6) and the C- 
terminus that pushes the HC2 p tyrosine towards 
its deoxy position [ 171. The same explanation can- 
not apply to Hb Roseau-Pointe a Pitre. Never- 
theless the new F6 glycine, by disturbing the struc- 
ture of the F helix, could affect in a similar way the 
contacts between the F helix and the C-terminus, 
favoring the deoxy structure, and introducing 
instability. 
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